Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_assertion type Assertion NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_head.
- NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_assertion description "[Preclinical evidence suggests that the molecular targeting of Plk1 could be an effective therapeutic strategy in a wide range of cancers; however, that success has yet to be translated to the clinical level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_provenance.
- NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_assertion evidence source_evidence_literature NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_provenance.
- NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_assertion SIO_000772 24265276 NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_provenance.
- NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_assertion wasDerivedFrom befree-20150227 NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_provenance.
- NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_assertion wasGeneratedBy ECO_0000203 NP630878.RAXpfInJrfMBLEZXUAkcPHLtTp_oS0YI7s5OulTMh0juQ130_provenance.